Clinical Trial Update: A Study of MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART) [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase 1/2 clinical trial evaluating MG7-targeted autologous CAR-T cells (MG7-CART) in patients with advanced MG7-positive liver metastase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases

Drugs mentioned

• MG7-CART (MG7-targeted autologous CAR-T cells)

Snippet

Sponsor: Xijing Hospital | Conditions: Liver Metastases | Phase 1, Phase 2 | Status: UNKNOWN